SCHEMBL1940574

SCHEMBL1940574

CC(C)n1cc(C(=O)c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2)c2c(N)ncnc21

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 6/20 0.71
ERBB2 P04626 6/20 0.71
ERBB3 P21860 6/20 0.71
TEK Q02763 6/20 0.71
ERBB4 Q15303 6/20 0.71
PDGFRB P09619 1/20 0.64
NTRK1 P04629 5/20 0.53
NTRK2 Q16620 3/20 0.53
NTRK3 Q16288 2/20 0.53
KCNH2 Q12809 3/20 0.52
KDR P35968 1/20 0.50
PDPK1 O15530 1/20 0.48
EIF2AK3 Q9NZJ5 2/20 0.47
RET P07949 4/20 0.45
LCK P06239 2/20 0.44
SRC P12931 2/20 0.44
PIK3CD O00329 1/20 0.42
PIK3CA P42336 1/20 0.42
PIK3CB P42338 1/20 0.42
PIK3CG P48736 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1939947 0.91 PDGFRB (0.62) EGFRERBB2ERBB3TEKERBB4
SCHEMBL4084085 0.91 NTRK1 (0.59) EGFRERBB2ERBB3TEKERBB4
SCHEMBL1941661 0.90 PDGFRB (0.69) EGFRERBB2ERBB3TEKERBB4
SCHEMBL1940563 0.89 PDGFRB (0.63) EGFRERBB2ERBB3TEKERBB4
SCHEMBL1941214 0.89 PDGFRB (0.63) EGFRERBB2ERBB3TEKERBB4
SCHEMBL1940398 0.89 PDGFRB (0.63) EGFRERBB2ERBB3TEKERBB4
SCHEMBL1940598 0.88 PDGFRB (0.60) EGFRERBB2ERBB3TEKERBB4
SCHEMBL1941510 0.88 PDGFRB (0.62) EGFRERBB2ERBB3TEKERBB4
SCHEMBL1939807 0.88 PDGFRB (0.62) EGFRERBB2ERBB3TEKERBB4
SCHEMBL1940727 0.88 PDGFRB (0.66) EGFRERBB2ERBB3TEKERBB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1578751-B1 PYRROLOPYRIMIDINE DERIVATIVES PFIZER PROD INC (US) 2011-06-15 EP disclosed
US-7271262-B2 Pyrrolopyrimidine derivatives PFIZER INC (US) 2007-09-18 US disclosed
EP-1578751-A1 PYRROLOPYRIMIDINE DERIVATIVES Pfizer Products Inc. (US) 2005-09-28 EP disclosed
US-20050037999-A1 Pyrrolopyrimidine derivatives PFIZER INC 2005-02-17 US disclosed
WO-2004056830-A1 PYRROLOPYRIMIDINE DERIVATIVES PFIZER PRODUCTS INC. (US) 2004-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050037999-A1 Pyrrolopyrimidine derivatives CCNA1, CCNT1, TP53 EGFR 2758/4885ERBB2 2738/4885ERBB3 3091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.